aprinox 2.5mg tablets
advanz pharma - bendroflumethiazide - oral tablet - 2.5mg
bendroflumethiazide 2.5mg tablets
p & d pharmaceuticals limited - bendroflumethiazide 2.5 mg - tablet
bendroflumethiazide
ipca pharma (nz) pty limited - bendroflumethiazide 5mg; ; - tablet - 5 mg - active: bendroflumethiazide 5mg excipient: lactose purified talc starch stearic acid - bendrofluazide is indicated in the treatment of oedema associated with conditions such as: congestive heart failure, nephrotic syndrome and cirrhosis of the liver.
arrow - bendrofluazide 5
teva pharma (new zealand) limited - bendroflumethiazide 5mg; ; - tablet - 5 mg - active: bendroflumethiazide 5mg excipient: lactose purified talc starch stearic acid - bendrofluazide is indicated in the treatment of oedema associated with conditions such as: congestive heart failure, nephrotic syndrome and cirrhosis of the liver.
bendroflumethiazide tablets 2.5mg
bristol laboratories limited unit 3, canalside, northbridge road, berkhamsted, hertfordshire, hp4 1eg, united kingdom - bendroflumethiazide - tablet - bendroflumethiazide 2.5 mg - diuretics
bendroflumethiazide tablets 2.5 mg
central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - bendroflumethiazide - tablet - bendroflumethiazide 2.5 mg - diuretics
bendroflumethiazide tablets 5mg
cherubino limited - bendroflumethiazide - tablet - bendroflumethiazide 5 mg - diuretics
neo-naclex 2.5mg tablets
advanz pharma - bendroflumethiazide - oral tablet - 2.5mg
bendroflumethiazide 2.5mg/5ml oral suspension
drug tariff special order - bendroflumethiazide - oral suspension - 500microgram/1ml
bendroflumethiazide 3.75mg/5ml oral suspension
special order - bendroflumethiazide - oral suspension - 750microgram/1ml